Champions Oncology Inc (CSBR)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-07-31 2025-01-31 2024-10-31 2024-07-31
Revenue 0 17,039,000 13,489,000 14,061,000
Cost of Revenue 7,995,000 6,617,000 7,072,000 7,072,000
Gross Profit -7,995,000 10,422,000 6,417,000 6,989,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 4,425,000 4,204,000 3,640,000 4,206,000
Operating Expenses 6,527,000 5,923,000 5,329,000 5,660,000
Operating Income -527,000 4,499,000 732,000 1,329,000
Interest Expense 0 0 0 0
Income Before Tax -452,000 4,518,000 739,000 1,334,000
Income Tax Expense 14,000 23,000 11,000 21,000
Net Income -466,000 4,495,000 728,000 1,313,000
Per Share
EPS -0.03 0.33 0.05 0.10
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Revenue 56,944,000 50,155,000 53,870,000 49,109,000 41,040,000
Cost of Revenue 28,389,000 29,401,000 29,532,000 23,632,000 21,446,000
Gross Profit 28,555,000 20,754,000 24,338,000 25,477,000 19,594,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 16,884,000 18,131,000 17,242,000 15,496,000 12,032,000
Operating Expenses 24,002,000 28,110,000 28,787,000 24,870,000 19,228,000
Operating Income 4,553,000 -7,356,000 -4,449,000 607,000 366,000
Interest Expense 27,000 0 0 24,000 0
Income Before Tax 4,626,000 -7,308,000 -5,267,000 583,000 437,000
Income Tax Expense -75,000 -32,000 68,000 35,000 75,000
Net Income 4,701,000 -7,276,000 -5,335,000 548,000 362,000
Per Share
EPS 0.34 -0.54 -0.39 0.04 0.03
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-04-30 2024-04-30 2023-04-30 2022-04-30
Assets
Cash and Cash Equivalents 9,785,000 2,618,000 10,118,000 9,007,000
Short Term Investments 0 0 0 0
Net Receivables 11,234,000 9,526,000 8,011,000 9,513,000
Inventory 0 0 1 0
Total Current Assets 22,369,000 13,639,000 19,457,000 19,664,000
Property Plant Equipment 9,455,000 11,973,000 14,504,000 15,364,000
Goodwill and Intangibles 335,000 335,000 335,000 335,000
Total Assets 32,344,000 26,132,000 34,311,000 35,378,000
Liabilities
Account Payables 4,248,000 5,800,000 5,334,000 2,868,000
Short Term Debt 1,471,000 1,337,000 1,208,000 1,054,000
Total Current Liabilities 23,853,000 21,541,000 21,733,000 17,479,000
Long Term Debt 4,634,000 6,093,000 7,391,000 8,412,000
Total Liabilities 28,572,000 28,035,000 29,675,000 26,282,000
Shareholders Equity
Retained Earnings -79,892,000 -84,593,000 -77,317,000 -71,982,000
Total Shareholders Equity 3,772,000 -1,903,000 4,636,000 9,096,000
Balance Sheet (Annual) 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Assets
Cash and Cash Equivalents 9,785,000 2,618,000 10,118,000 9,007,000 4,687,000
Short Term Investments 0 0 0 0 0
Net Receivables 11,234,000 9,526,000 8,011,000 9,513,000 6,986,000
Inventory 0 0 1 0 0
Total Current Assets 22,369,000 13,639,000 19,457,000 19,664,000 12,630,000
Property Plant Equipment 9,455,000 11,973,000 14,504,000 15,364,000 14,611,000
Goodwill and Intangibles 335,000 335,000 335,000 335,000 335,000
Total Assets 32,344,000 26,132,000 34,311,000 35,378,000 27,591,000
Liabilities
Account Payables 4,248,000 5,800,000 5,334,000 2,868,000 1,894,000
Short Term Debt 1,471,000 1,337,000 1,208,000 1,054,000 818,000
Total Current Liabilities 23,853,000 21,541,000 21,733,000 17,479,000 11,199,000
Long Term Debt 4,634,000 6,093,000 7,391,000 8,412,000 8,783,000
Total Liabilities 28,572,000 28,035,000 29,675,000 26,282,000 20,163,000
Shareholders Equity
Retained Earnings -79,892,000 -84,593,000 -77,317,000 -71,982,000 -72,530,000
Total Shareholders Equity 3,772,000 -1,903,000 4,636,000 9,096,000 7,428,000
Cash Flow Statement (Quarterly) 2025-04-30 2024-04-30 2023-04-30 2022-04-30
Operating Activities
Net Income 4,701,000 -7,276,000 -5,335,000 548,000
Depreciation & Amortization 1,640,000 1,867,000 2,246,000 1,627,000
Stock Based Compensation 654,000 1,118,000 864,000 912,000
Change in Working Capital -621,000 -3,823,000 4,226,000 2,336,000
Operating Cash Flow 7,386,000 -6,137,000 3,955,000 6,497,000
Investing Activities
Capital Expenditure -389,000 -836,000 -2,872,000 -2,384,000
Investments -389,000 -836,000 -2,872,000 -2,384,000
Investing Cash Flow -389,000 -836,000 -2,872,000 -2,384,000
Financing Activities
Debt Repayment -150,000 -146,000 0 0
Common Stock Issued/Repurchased 320,000 -634,000 11,000 207,000
Dividends Paid 0 0 0 0
Financing Cash Flow 170,000 -527,000 11,000 207,000
Summary
Free Cash Flow 6,997,000 -6,973,000 1,083,000 4,113,000
Net Change in Cash 7,167,000 -7,500,000 1,094,000 4,320,000
Cash Flow Statement (Annual) 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Operating Activities
Net Income 4,701,000 -7,276,000 -5,335,000 548,000 362,000
Depreciation & Amortization 1,640,000 1,867,000 2,246,000 1,627,000 1,184,000
Stock Based Compensation 654,000 1,118,000 864,000 912,000 598,000
Change in Working Capital -621,000 -3,823,000 4,226,000 2,336,000 -4,197,000
Operating Cash Flow 7,386,000 -6,137,000 3,955,000 6,497,000 -1,681,000
Investing Activities
Capital Expenditure -389,000 -836,000 -2,872,000 -2,384,000 -3,281,000
Investments -389,000 -836,000 -2,872,000 -2,384,000 -3,281,000
Investing Cash Flow -389,000 -836,000 -2,872,000 -2,384,000 -3,169,000
Financing Activities
Debt Repayment -150,000 -146,000 0 0 -174,000
Common Stock Issued/Repurchased 320,000 -634,000 11,000 207,000 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow 170,000 -527,000 11,000 207,000 1,195,000
Summary
Free Cash Flow 6,997,000 -6,973,000 1,083,000 4,113,000 -4,962,000
Net Change in Cash 7,167,000 -7,500,000 1,094,000 4,320,000 -3,655,000